TScan Therapeutics (TCRX) Share-based Compensation (2020 - 2026)
TScan Therapeutics' Share-based Compensation came in at $2.08 million for Q3 2026, down 31.0% from $3.01 million a year earlier and down 11.9% from the prior quarter.
TScan Therapeutics (TCRX) Share-based Compensation (2020 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, TScan Therapeutics reported Share-based Compensation of $8.91 million, down 28.2% year-over-year; for FY2025, it was $11.71 million, up 22.6% from FY2024.
- Share-based Compensation has increased in each of the last five years, with a five-year compound annual growth rate of 86.8% (FY2020 to FY2025).
- Going back by year, Share-based Compensation was $9.55 million in FY2024 (+83.4%), $5.21 million in FY2023 (+14.4%), $4.55 million in FY2022 (+80.9%) and $2.52 million in FY2021 (+388.5%).
- The five-year range for quarterly Share-based Compensation is $784,000 (Q4 2021) to $3.41 million (Q1 2025).
- Year-over-year, Share-based Compensation has declined for four consecutive quarters, with growth averaging 12.5% over the last eight quarters.
- The fastest year-over-year change in Share-based Compensation over five years came in Q4 2021 (growth of 422.7%), and the weakest in Q3 2026 (a decline of 31.0%).
- Business Quant data shows TCRX's Share-based Compensation at $2.36 million (Q2 2026), $2.47 million (Q1 2026) and $2.01 million (Q4 2025) in the three quarters before Q3 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | PetVivo Holdings | 3,096.39 Bn | 3,096.39 Bn | 196,075.00 | 372,681.00 |
| 2 | Eli Lilly | 1,202.70 Bn | 1,176.32 Bn | 20.46 Bn | 200.00 Mn |
| 3 | Johnson & Johnson | 649.77 Bn | 569.63 Bn | 17.30 Bn | 357.00 Mn |
| 4 | AbbVie | 507.00 Bn | 475.00 Bn | 13.12 Bn | 160.00 Mn |
| 5 | Merck | 329.70 Bn | 292.64 Bn | 13.19 Bn | 369.00 Mn |
| 6 | Novartis Ag | 291.91 Bn | 265.14 Bn | - | - |
| 7 | Amgen | 236.26 Bn | 187.91 Bn | 7.58 Bn | 128.00 Mn |
| 8 | Gilead Sciences | 207.15 Bn | 182.26 Bn | 6.73 Bn | 234.00 Mn |
| 9 | Gsk | 193.54 Bn | 176.38 Bn | - | - |
| 10 | TScan Therapeutics | 18.87 Mn | -434.83 Mn | - | 2.08 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 2.08 Mn |
| Jun 30, 2026 | 2.36 Mn |
| Mar 31, 2026 | 2.47 Mn |
| Dec 31, 2025 | 2.01 Mn |
| Sep 30, 2025 | 3.01 Mn |
| Jun 30, 2025 | 3.27 Mn |
| Mar 31, 2025 | 3.41 Mn |
| Dec 31, 2024 | 2.71 Mn |
| Sep 30, 2024 | 2.52 Mn |
| Jun 30, 2024 | 2.33 Mn |
| Mar 31, 2024 | 1.98 Mn |
| Dec 31, 2023 | 1.50 Mn |
| Sep 30, 2023 | 1.34 Mn |
| Jun 30, 2023 | 1.22 Mn |
| Mar 31, 2023 | 1.15 Mn |
| Dec 31, 2022 | 1.30 Mn |
| Sep 30, 2022 | 1.25 Mn |
| Jun 30, 2022 | 1.02 Mn |
| Mar 31, 2022 | 984,000.00 |
| Dec 31, 2021 | 784,000.00 |
TScan Therapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=TCRX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "TCRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=TCRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();